These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 28476813)

  • 21. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
    Wang G; Gu J; Gao Y
    Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyr61 promotes breast tumorigenesis and cancer progression.
    Tsai MS; Bogart DF; Castañeda JM; Li P; Lupu R
    Oncogene; 2002 Nov; 21(53):8178-85. PubMed ID: 12444554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice.
    Sabile AA; Arlt MJ; Muff R; Husmann K; Hess D; Bertz J; Langsam B; Aemisegger C; Ziegler U; Born W; Fuchs B
    Biochim Biophys Acta; 2013 Aug; 1832(8):1173-82. PubMed ID: 23528710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway.
    Lin MT; Zuon CY; Chang CC; Chen ST; Chen CP; Lin BR; Wang MY; Jeng YM; Chang KJ; Lee PH; Chen WJ; Kuo ML
    Clin Cancer Res; 2005 Aug; 11(16):5809-20. PubMed ID: 16115920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cysteine-rich 61 (CYR61) inhibits cisplatin-induced apoptosis in ovarian carcinoma cells.
    Rho SB; Woo JS; Chun T; Park SY
    Biotechnol Lett; 2009 Jan; 31(1):23-8. PubMed ID: 18800188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYR61 Confers the Sensitivity to Aromatase Inhibitor Letrozole in ER Positive Breast Carcinoma.
    Jia X; Liu G; Cheng J; Shen Z; Shao Z
    Curr Cancer Drug Targets; 2017; 17(2):191-197. PubMed ID: 27113745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression.
    Chen C; Ge C; Liu Z; Li L; Zhao F; Tian H; Chen T; Li H; Yao M; Li J
    J Exp Clin Cancer Res; 2018 Oct; 37(1):263. PubMed ID: 30376856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevation of angiogenic factor Cysteine-rich 61 levels in vitreous of patients with proliferative diabetic retinopathy.
    You JJ; Yang CM; Chen MS; Yang CH
    Retina; 2012 Jan; 32(1):103-11. PubMed ID: 21822163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between Cyr61 expression and clinicopathologic parameters in adenomyosis.
    Zhang D; Xia W; Tong T; Li C; Shi W; Yan MX; Xue RH; Guan XM; Zhang J
    J Reprod Immunol; 2016 Nov; 118():42-49. PubMed ID: 27644084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
    Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
    J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of altered expression of SDC2 and CYR61 in esophageal squamous cell carcinoma.
    Huang X; Xiao DW; Xu LY; Zhong HJ; Liao LD; Xie ZF; Li EM
    Oncol Rep; 2009 Apr; 21(4):1123-9. PubMed ID: 19288017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer.
    Huber MC; Falkenberg N; Hauck SM; Priller M; Braselmann H; Feuchtinger A; Walch A; Schmitt M; Aubele M
    Oncotarget; 2016 Jul; 7(28):44062-44075. PubMed ID: 27286449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and significance of Cyr61 in distant metastasis cells of human primary salivary adenoid cystic carcinoma.
    Tang QL; Chen WL; Tan XY; Li HG; Yuan XP; Fan S; Wen B; Song Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):228-36. PubMed ID: 21601497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes.
    Kwon EJ; Park EJ; Choi S; Kim SR; Cho M; Kim J
    Int J Rheum Dis; 2017 Oct; 20(10):1499-1509. PubMed ID: 27456070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression.
    Huang YT; Lan Q; Ponsonnet L; Blanquet M; Christofori G; Zaric J; Rüegg C
    Oncotarget; 2016 Jan; 7(2):1663-74. PubMed ID: 26625209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyr61 as mediator of Src signaling in triple negative breast cancer cells.
    Sánchez-Bailón MP; Calcabrini A; Mayoral-Varo V; Molinari A; Wagner KU; Losada JP; Ciordia S; Albar JP; Martín-Pérez J
    Oncotarget; 2015 May; 6(15):13520-38. PubMed ID: 25980494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.
    Feng P; Wang B; Ren EC
    Int J Biochem Cell Biol; 2008; 40(1):98-109. PubMed ID: 17698398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells.
    Chin LH; Hsu SP; Zhong WB; Liang YC
    Mol Carcinog; 2016 May; 55(5):622-32. PubMed ID: 25773758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.